Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 202

1.

The caveolin-1 regulated protein follistatin protects against diabetic kidney disease.

Zhang D, Gava AL, Van Krieken R, Mehta N, Li R, Gao B, Desjardins EM, Steinberg GR, Hawke T, Krepinsky JC.

Kidney Int. 2019 Jun 17. pii: S0085-2538(19)30618-0. doi: 10.1016/j.kint.2019.05.032. [Epub ahead of print]

PMID:
31492508
2.

Can social firms contribute to alleviating the economic burden of psychiatric disabilities for the public healthcare system?

Sultan-Taïeb H, Villotti P, Berbiche D, Dewa CS, Desjardins É, Fraccaroli F, Zaniboni S, Mazaniello-Chézol M, Lecomte T, Durand MJ, Corbière M.

Health Soc Care Community. 2019 Sep;27(5):1311-1320. doi: 10.1111/hsc.12775. Epub 2019 May 31.

PMID:
31149764
3.

Emerging Role of AMPK in Brown and Beige Adipose Tissue (BAT): Implications for Obesity, Insulin Resistance, and Type 2 Diabetes.

Desjardins EM, Steinberg GR.

Curr Diab Rep. 2018 Aug 17;18(10):80. doi: 10.1007/s11892-018-1049-6. Review.

PMID:
30120579
4.

Family conflict and future concerns: Opportunities for social workers to better support Chinese immigrant caregiver employees.

Sethi B, Williams A, Desjardins E, Zhu H, Shen E.

J Gerontol Soc Work. 2018 May-Jun;61(4):375-392. doi: 10.1080/01634372.2017.1419395. Epub 2018 Jan 24.

PMID:
29261434
5.

Ablating the protein TBC1D1 impairs contraction-induced sarcolemmal glucose transporter 4 redistribution but not insulin-mediated responses in rats.

Whitfield J, Paglialunga S, Smith BK, Miotto PM, Simnett G, Robson HL, Jain SS, Herbst EAF, Desjardins EM, Dyck DJ, Spriet LL, Steinberg GR, Holloway GP.

J Biol Chem. 2017 Oct 6;292(40):16653-16664. doi: 10.1074/jbc.M117.806786. Epub 2017 Aug 14.

6.

FGF21 does not require adipocyte AMP-activated protein kinase (AMPK) or the phosphorylation of acetyl-CoA carboxylase (ACC) to mediate improvements in whole-body glucose homeostasis.

Mottillo EP, Desjardins EM, Fritzen AM, Zou VZ, Crane JD, Yabut JM, Kiens B, Erion DM, Lanba A, Granneman JG, Talukdar S, Steinberg GR.

Mol Metab. 2017 Apr 5;6(6):471-481. doi: 10.1016/j.molmet.2017.04.001. eCollection 2017 Jun.

7.

Are SIRT1 activators another indirect method to increase AMPK for beneficial effects on aging and the metabolic syndrome?

Ford RJ, Desjardins EM, Steinberg GR.

EBioMedicine. 2017 May;19:16-17. doi: 10.1016/j.ebiom.2017.04.027. Epub 2017 Apr 20. No abstract available.

8.

Muramyl Dipeptide-Based Postbiotics Mitigate Obesity-Induced Insulin Resistance via IRF4.

Cavallari JF, Fullerton MD, Duggan BM, Foley KP, Denou E, Smith BK, Desjardins EM, Henriksbo BD, Kim KJ, Tuinema BR, Stearns JC, Prescott D, Rosenstiel P, Coombes BK, Steinberg GR, Schertzer JD.

Cell Metab. 2017 May 2;25(5):1063-1074.e3. doi: 10.1016/j.cmet.2017.03.021. Epub 2017 Apr 20.

9.

Myostatin inhibition therapy for insulin-deficient type 1 diabetes.

Coleman SK, Rebalka IA, D'Souza DM, Deodhare N, Desjardins EM, Hawke TJ.

Sci Rep. 2016 Sep 1;6:32495. doi: 10.1038/srep32495.

10.

Treatment of nonalcoholic fatty liver disease: role of AMPK.

Smith BK, Marcinko K, Desjardins EM, Lally JS, Ford RJ, Steinberg GR.

Am J Physiol Endocrinol Metab. 2016 Oct 1;311(4):E730-E740. doi: 10.1152/ajpendo.00225.2016. Epub 2016 Aug 30. Review.

11.

Salsalate (Salicylate) Uncouples Mitochondria, Improves Glucose Homeostasis, and Reduces Liver Lipids Independent of AMPK-β1.

Smith BK, Ford RJ, Desjardins EM, Green AE, Hughes MC, Houde VP, Day EA, Marcinko K, Crane JD, Mottillo EP, Perry CG, Kemp BE, Tarnopolsky MA, Steinberg GR.

Diabetes. 2016 Nov;65(11):3352-3361. Epub 2016 Aug 23.

12.

Lack of Adipocyte AMPK Exacerbates Insulin Resistance and Hepatic Steatosis through Brown and Beige Adipose Tissue Function.

Mottillo EP, Desjardins EM, Crane JD, Smith BK, Green AE, Ducommun S, Henriksen TI, Rebalka IA, Razi A, Sakamoto K, Scheele C, Kemp BE, Hawke TJ, Ortega J, Granneman JG, Steinberg GR.

Cell Metab. 2016 Jul 12;24(1):118-29. doi: 10.1016/j.cmet.2016.06.006.

13.

PROMOTING RESILIENCE.

Desjardins E, Barker G, Lindo Z, Dieleman C, Dussault AC.

Q Rev Biol. 2015 Jun;90(2):147-65. Review.

PMID:
26285353
14.

PGC-1α modulates denervation-induced mitophagy in skeletal muscle.

Vainshtein A, Desjardins EM, Armani A, Sandri M, Hood DA.

Skelet Muscle. 2015 Mar 18;5:9. doi: 10.1186/s13395-015-0033-y. eCollection 2015.

15.

Gamification of dietary decision-making in an elementary-school cafeteria.

Jones BA, Madden GJ, Wengreen HJ, Aguilar SS, Desjardins EA.

PLoS One. 2014 Apr 9;9(4):e93872. doi: 10.1371/journal.pone.0093872. eCollection 2014.

16.

Giving voice to food insecurity in a remote indigenous community in subarctic Ontario, Canada: traditional ways, ways to cope, ways forward.

Skinner K, Hanning RM, Desjardins E, Tsuji LJ.

BMC Public Health. 2013 May 2;13:427. doi: 10.1186/1471-2458-13-427.

17.

Collaborating to combat childhood obesity.

Desjardins E, Schwartz AL.

Health Aff (Millwood). 2007 Mar-Apr;26(2):567-71. Review.

PMID:
17339687
18.

Foundations' roles in transforming the mental health care system.

LeRoy L, Heldring M, Desjardins E.

Health Aff (Millwood). 2006 Jul-Aug;25(4):1168-71.

PMID:
16835200
19.
20.

Evidence-based strategies to build community food security.

McCullum C, Desjardins E, Kraak VI, Ladipo P, Costello H.

J Am Diet Assoc. 2005 Feb;105(2):278-83. No abstract available.

PMID:
15668689
21.

Identification of bacteria contaminating pulp and a paper machine in a Canadian paper mill.

Desjardins E, Beaulieu C.

J Ind Microbiol Biotechnol. 2003 Mar;30(3):141-5. Epub 2003 Jan 14.

PMID:
12715250
23.

Probability analysis of variational crystallization and its application to gp120, the exterior envelope glycoprotein of type 1 human immunodeficiency virus (HIV-1).

Kwong PD, Wyatt R, Desjardins E, Robinson J, Culp JS, Hellmig BD, Sweet RW, Sodroski J, Hendrickson WA.

J Biol Chem. 1999 Feb 12;274(7):4115-23.

24.

The envelope glycoprotein ectodomains determine the efficiency of CD4+ T lymphocyte depletion in simian-human immunodeficiency virus-infected macaques.

Karlsson GB, Halloran M, Schenten D, Lee J, Racz P, Tenner-Racz K, Manola J, Gelman R, Etemad-Moghadam B, Desjardins E, Wyatt R, Gerard NP, Marcon L, Margolin D, Fanton J, Axthelm MK, Letvin NL, Sodroski J.

J Exp Med. 1998 Sep 21;188(6):1159-71.

25.

Stabilization of human immunodeficiency virus type 1 envelope glycoprotein trimers by disulfide bonds introduced into the gp41 glycoprotein ectodomain.

Farzan M, Choe H, Desjardins E, Sun Y, Kuhn J, Cao J, Archambault D, Kolchinsky P, Koch M, Wyatt R, Sodroski J.

J Virol. 1998 Sep;72(9):7620-5.

26.

The antigenic structure of the HIV gp120 envelope glycoprotein.

Wyatt R, Kwong PD, Desjardins E, Sweet RW, Robinson J, Hendrickson WA, Sodroski JG.

Nature. 1998 Jun 18;393(6686):705-11.

PMID:
9641684
27.

Analysis of the interaction of antibodies with a conserved enzymatically deglycosylated core of the HIV type 1 envelope glycoprotein 120.

Binley JM, Wyatt R, Desjardins E, Kwong PD, Hendrickson W, Moore JP, Sodroski J.

AIDS Res Hum Retroviruses. 1998 Feb 10;14(3):191-8.

PMID:
9491908
28.

A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5.

Farzan M, Choe H, Vaca L, Martin K, Sun Y, Desjardins E, Ruffing N, Wu L, Wyatt R, Gerard N, Gerard C, Sodroski J.

J Virol. 1998 Feb;72(2):1160-4.

29.

CD4-independent binding of SIV gp120 to rhesus CCR5.

Martin KA, Wyatt R, Farzan M, Choe H, Marcon L, Desjardins E, Robinson J, Sodroski J, Gerard C, Gerard NP.

Science. 1997 Nov 21;278(5342):1470-3.

31.

Stainless steel mesh supports high density cell growth and production of recombinant müllerian inhibiting substances.

Epstein J, Desjardins EJ, Hudson PL, Donahoe PK.

In Vitro Cell Dev Biol. 1989 Feb;25(2):213-6.

PMID:
2921237
32.

Commitment to caring.

Desjardins EJ.

Hosp Trustee. 1981 Mar-Apr;5(2):6-8. No abstract available.

PMID:
10253384
33.

[Doctor Gabriel Nadeau (1900-1979)].

Desjardins E.

Union Med Can. 1979 Apr;108(4):447. French. No abstract available.

PMID:
388781
34.

[Doctor Jean-Baptiste Jobert (1733--1792)].

Desjardins E.

Union Med Can. 1979 Feb;108(2):200. French. No abstract available.

PMID:
384639
35.

[Dr. Wilder Graves Penfield (1890--1973)].

Desjardins E.

Union Med Can. 1979 Jan;108(1):100,103. French. No abstract available.

PMID:
373203
36.

[Biography of physicians in Quebec].

Desjardins E.

Union Med Can. 1979 Jan;108(1):100, 103. French. No abstract available.

PMID:
373202
37.

[Biographies of Quebec physicians].

Desjardins E.

Union Med Can. 1978 Dec;107(12):1185-6. French. No abstract available.

PMID:
362661
38.

[Dr. Albiny Paquette (1889-1978)].

Desjardins E.

Union Med Can. 1978 Nov;107(11):1045. French. No abstract available.

PMID:
362657
39.

[Biographies of Quebec physicians].

Desjardins E.

Union Med Can. 1978 Oct;107(10):984-7. French. No abstract available.

PMID:
360542
40.

[Biographies of Quebec physicians].

Desjardins E.

Union Med Can. 1978 Sep;107(9):873-8. French. No abstract available.

PMID:
360546
41.

Dr. Joseph Alexandre Crevier (1824--1889)

Desjardins E.

Union Med Can. 1978 Aug;107(8):764. No abstract available.

PMID:
354152
42.

[Dr. Robert Craik (1829-1906)].

Desjardins E.

Union Med Can. 1978 Aug;107(8):764. French. No abstract available.

PMID:
354151
43.

[Dr. Joseph Emery-Coderre, a stubborn contestant].

Lapointe L, Desjardins E.

Union Med Can. 1977 Dec;106(12):1664-71, 1680-5. French. No abstract available.

PMID:
341457
44.

[The development of medicine in Quebec: VIII].

Desjardins E.

Union Med Can. 1977 Nov;106(11):1549-44, 1546, 1549-50 passim. French. No abstract available.

PMID:
337611
45.

[The development of medicine in Quebec: VII].

Desjardins E.

Union Med Can. 1977 Oct;106(10):1416-38. French. No abstract available.

PMID:
339460
46.

[Evolution of medicine in Quebec: V].

Desjardins E.

Union Med Can. 1977 Sep;106(9):1284-315. French. No abstract available.

PMID:
333692
47.

[Dr. Antonio Demers].

Desjardins E.

Union Med Can. 1977 Sep;106(9):1212-3. French. No abstract available.

PMID:
333691
48.

[The evolution of surgery in Quebec: VII].

Desjardins E.

Union Med Can. 1977 Sep;106(9):1198-211 contd. French. No abstract available.

PMID:
333689
49.

[Transmission of a national heritage].

Desjardins E.

Union Med Can. 1977 Aug;106(8):1089-90. French. No abstract available.

PMID:
906149
50.

[Development of surgery in Quebec. VI].

Desjardins E.

Union Med Can. 1977 Aug;106(8):1172, 1177 passim. French. No abstract available.

PMID:
333688

Supplemental Content

Loading ...
Support Center